Different activity of ATP dependent transport across the canalicular membrane for tributylmethylammonium and triethylmethylammonium as a potential mechanism of the preferential biliary excretion for tributylmethylammonium in the rat

Pharmaceutical Research

Volumn 16, Issue 4, 1999, Pages 540-544

  Song, Im Sook ^a   Chung, Suk Jae ^a   Shim, Chang Koo ^a  

^a Seoul National University   (South Korea)

Author keywords

Biliary excretion; cLPM; Organic cation H+ exchanger; P glycoprotein; TBuMA; TEMA

Indexed keywords

ADENOSINE TRIPHOSPHATE; AMMONIUM DERIVATIVE; GLYCOPROTEIN P; TRIBUTYLMETHYLAMMONIUM; TRIETHYLMETHYLAMMONIUM; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BILIARY EXCRETION; CONTROLLED STUDY; DRUG TRANSPORT; INTRAHEPATIC BILE DUCT; LIVER CELL MEMBRANE; MALE; NONHUMAN; PH; PRIORITY JOURNAL; PROTON TRANSPORT; RAT;

EID: 0032927215     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1018823113314     Document Type: Article

References (25)

1. 1. R. D. Hughes, P. Millburn, and R. T. Williams. Molecular weight as a factor in the excretion of monoquaternary ammonium cations in the rat, guinea pig and rabbit. Biochem. J. 136:967-978 (1973).
2. 2. R. D. Hughes, P. Millburn, and R. T. Williams. Biliary excretion of some diquaternary ammonium cations in the rat, guinea pig and rabbit. Biochem. J. 136:979-984 (1973).
3. 3. C. Neef, R. Oosting, and D. K. F. Meijer. Structure-pharmacokinetics relationship of quaternary ammonium compounds. Naunyn-Schmiedeberg's Arch. Pharmacol. 328:103-110 (1984).
4. 4. Y. H. Han. Kinetic analysis of hepato-biliary transport of organic cations. Thesis, Seoul National University, Korea (1995).
5. 5. R. H. Moseley, S. M. Jarose, and P. Permoad. Organic cation transport by rat liver plasma membrane vesicles: studies with tetraethylammonium. Am. J. Physiol. 263:G775-G785 (1992).
6. 6. R. H. Moseley, H. Smit, B. G. H. Van Solkema, W. Wang, and D. K. F. Meijer. Mechanisms for the hepatic uptake and biliary excretion of tributylmethyl ammonium: Studies with rat liver plasma membrane vesicles. J. Pharmacol. Exp. Ther. 276:561-567 (1996).
7. 7. D. K. F. Meijer, J. W. Smit, and M. Muller. Hepatobiliary elimination of cationic drugs: the role of P-glycoproteins and other ATP dependent transporters. Adv. Drug Del. Rev. 25:159-200 (1997).
8. 8. J. W. Smit, E. Duin, H. Steen, R. Oosting, J. Roggeveld, and D. K. F. Meijer. Interactions between P-glycoprotein substrates and other cationic drugs at the hepatic excretory level. Br. J. Pharmacol. 123:361-370 (1998).
9. 9. A. Dutt, L. A. Heath, and J. A. Nelson. P-glycoprotein and organic cation secretion by the mammalian kidney. J. Pharmacol. Exp. Ther. 269:1254-1260 (1994).
10. 3H]-1-methyl-4-phenylpyridinium in rat isolated hepatocytes: putative involvement of a P-glycoprotein transporter. Br. J. Pharmacol. 119:1519-1524 (1996).
11. 11. J. W. Smit, B. Weert, A. H. Schinkel, and D. K. F. Meijer. Hepatologous expression of various P-glycoproteins in polarized epithelial cells induces directional transport of small (type 1) and bulky (type 2) cationic drugs. J. Pharmacol. Exp. Ther. 286:321-327 (1998).
12. 12. J. W. Smit, A. H. Schinkel, M. Muller, B. Weert, and D. K. F. Meijer. Contribution of the murine mdrla P-glycoprotein to hepatobiliary and intestinal elimination of cationic drugs as measured in mice with an mdrla gene disruption. Hepalology 27:1056-1063 (1998).
13. 13. J. W. Smit, A. H. Schinkel, M. Muller, B. Weert, and D. K. F. Meijer. Hepatobiliary and intestinal clearance of amphiphilic cationic drugs in mice which both mdrla and mdrlb genes have been disrupted. Br. J. Pharmacol. 124:416-424 (1998).
14. 14. C. Neef, K. T. P. Keulemans, and D. K. F. Meijer. Hepatic uptake and biliary excretion of organic cations. Biochem. Pharmacol. 33:3977-3990 (1984).
15. 15. M. Inoue, R. Kinne, T. Tran, L. Biempica and I. M. Arias. Rat liver canalicular membrane vesicles: isolation and topological characterization. J. Biol. Chem. 258:5183-5188 (1983).
16. 16. J. M. Pekarthy, J. Short, A. I. Lansing, and I. Leiberman. Function and control of liver alkaline phosphatase. J. Biol. Chem. 247:1767-1774 (1972).
17. 17. O. H. Lowry, N. J. Rosebrough, A. L. Farr, and R. J. Randall. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193:265-275 (1951).
18. 18. L. Warren. The Thiobarbituric acid assay of sialic acids. J. Biol. Chem. 234:1971-1975 (1959).
19. 19. J. C. Fernandez-Checa, H. Takikawa, T. Horie, M. Ookhtens, and N. Kaplowitz. Canalicular transport of reduced glutathione in normal and mutant Eisai hyperbilirubinemic rats. J. Biol. Chem. 267:1667-1673 (1992).
20. 20. J. C. Fernandez-Checa, M. Ookhtens, and N. Kaplowitz. Selective induction by phenobarbital of the electrogenic transport of glutathione and organic anions in rat liver canicular membrane vesicles. J. Biol. Chem. 268:10836-10541 (1993).
21. 21. B. Stieger, B. O'neill, and P. J. Meier. ATP-dependent bile-salt transport in canalicular rat liver plasma membrane vesicles. Biochem. J. 284:67-74 (1992).
22. 22. T. Nishida, Z. Gatmaitan, M. Che, and I. M. Arias. Rat liver canalicular membrane vesicles contain an ATP-dependent bile acid transport system. Proc. Natl. Acad. Sci. USA 88:6590-6594 (1991).
23. 23. B. L. Blizer and C. B. Donovan. A new method for the rapid isolation of basolateral plasma membrane vesicles from rat liver: characterization, validation and bile acid transport studies. J. Biol. Chem. 259:9295-9301 (1984).
24. 24. Y. G. Kwon, A. V. Kamath, and M. E. Morris. Inhibitors of P-glycoprotein-mediated daunomycin transport in rat liver canalicular membrane vesicles. J. Pharm. Sci. 85:935-938 (1996).
25. 25. Y. Kamimoto, Z. Gatmaitan, J. Hsu, and I. M. Arias. The function of Gpl70, the multidrug resistance gene product, in rat liver canalicular membrane vesicles. J. Biol. Chem. 264:11693-11698 (1989).